Clinical Benefit of Pembrolizumab in Advanced Urothelial Cancer Patients in Real-Life Setting: An Efficacy and Safety Monocentric Study.

Elodie DangAlexandre ValléeCoralie Lepage-SeydouxKarine SejeanBrigitte BonanChristine AbrahamPhilippe BeuzebocRaffaele Ratta

Published in: Current oncology (Toronto, Ont.) (2022)

Our results confirmed those of randomized clinical trials concerning the treatment with pembrolizumab in patients with advanced UC that progressed after platinum-based chemotherapy.

Keyphrases

advanced non small cell lung cancer
locally advanced
squamous cell carcinoma
combination therapy
urinary tract
tyrosine kinase